Novartis (NVS) EV/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 13.4 | 12.0 | 12.2 | 10.3 | 12.7 | 14.4 | ||
| Changes by years, y/y, % | +6% | -11% | +2% | -15% | +23% | -3.3% | |||
Novartis. EV/EBITDA
Novartis. EV/EBITDA, changes, %
Novartis (NVS) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 11.1 | 11.5 | 11.4 | 12.7 | 14.8 | 14.4 | |
| Changes by years, y/y, % | -5% | -8% | -10% | +24% | +33% | |||
| Changes by quarters, q/q, % | +9% | +3% | -1% | +11% | +17% | |||